The solubility-permeability interplay when using cosolvents for solubilization: revising the way we use solubility-enabling formulations
- PMID: 22280478
- DOI: 10.1021/mp200460u
The solubility-permeability interplay when using cosolvents for solubilization: revising the way we use solubility-enabling formulations
Abstract
We have recently reported the interplay between apparent aqueous solubility and intestinal membrane permeability, showing the trade-off between the two when using cyclodextrin- and surfactant-based systems as solubility-enabling formulations. In these cases, the decreased permeability could be attributed directly to decreased free fraction of drug due to the complexation/micellization inherent in these solubilization methods. The purpose of this study was to investigate the direct solubility-permeability interplay, using formulations in which complexation is not the mechanism for increased solubilization. The apparent aqueous solubility (S(aq)) and rat intestinal permeability (P(eff)) of the lipophilic drug progesterone were measured in systems containing various levels of the cosolvents propylene glycol and PEG-400, since this solubilization method does not involve decreased free fraction. Thermodynamic activity was maintained equivalent in all permeability studies (75% equilibrium solubility). Both cosolvents increased progesterone S(aq) in nonlinear fashion. Decreased P(eff) with increased S(aq) was observed, despite the constant thermodynamic activity, and the nonrelevance of free fraction. A mass-transport analysis was developed to describe this interplay. The model considers the effects of solubilization on the membrane permeability (P(m)) and the unstirred water layer (UWL) permeability (P(aq)), to predict the overall P(eff) dependence on S(aq). The analysis revealed that (1) the effective UWL thickness quickly decreases with ↑S(aq), such that P(aq) markedly increases with ↑S(aq); (2) the apparent membrane/aqueous partitioning decreases with ↑S(aq), thereby reducing the thermodynamic driving force for permeability such that ↓P(m) with ↑S(aq); (3) since ↑P(aq) and ↓P(m) with ↑S(aq), the UWL is shorted out and P(eff) becomes membrane control with ↑S(aq). The model enabled excellent quantitative prediction of P(eff) as a function of S(aq). This work demonstrates that a direct trade-off exists between the apparent solubility and permeability, which must be taken into account when developing solubility-enabling formulations to strike the optimal solubility-permeability balance, in order to maximize the overall oral absorption.
Similar articles
-
The solubility-permeability interplay: mechanistic modeling and predictive application of the impact of micellar solubilization on intestinal permeation.Mol Pharm. 2011 Oct 3;8(5):1848-56. doi: 10.1021/mp200181v. Epub 2011 Aug 11. Mol Pharm. 2011. PMID: 21800883
-
Accounting for the solubility-permeability interplay in oral formulation development for poor water solubility drugs: the effect of PEG-400 on carbamazepine absorption.Eur J Pharm Biopharm. 2012 Jun;81(2):386-91. doi: 10.1016/j.ejpb.2012.02.012. Epub 2012 Feb 24. Eur J Pharm Biopharm. 2012. PMID: 22387337
-
The solubility-permeability interplay in using cyclodextrins as pharmaceutical solubilizers: mechanistic modeling and application to progesterone.J Pharm Sci. 2010 Jun;99(6):2739-49. doi: 10.1002/jps.22033. J Pharm Sci. 2010. PMID: 20039391
-
Active intestinal drug absorption and the solubility-permeability interplay.Int J Pharm. 2018 Feb 15;537(1-2):84-93. doi: 10.1016/j.ijpharm.2017.10.058. Epub 2017 Nov 2. Int J Pharm. 2018. PMID: 29102702 Review.
-
The solubility-permeability interplay and its implications in formulation design and development for poorly soluble drugs.AAPS J. 2012 Jun;14(2):244-51. doi: 10.1208/s12248-012-9337-6. Epub 2012 Mar 6. AAPS J. 2012. PMID: 22391790 Free PMC article. Review.
Cited by
-
The inhibiting role of hydroxypropylmethylcellulose acetate succinate on piperine crystallization to enhance its dissolution from its amorphous solid dispersion and permeability.RSC Adv. 2019 Dec 3;9(67):39523-39531. doi: 10.1039/c9ra08283b. eCollection 2019 Nov 27. RSC Adv. 2019. PMID: 35540632 Free PMC article.
-
Mechanisms and Extent of Enhanced Passive Permeation by Colloidal Drug Particles.Mol Pharm. 2022 Sep 5;19(9):3085-3099. doi: 10.1021/acs.molpharmaceut.2c00124. Epub 2022 Aug 23. Mol Pharm. 2022. PMID: 35998304 Free PMC article.
-
Challenges and Strategies in Thermal Processing of Amorphous Solid Dispersions: A Review.AAPS PharmSciTech. 2016 Feb;17(1):43-55. doi: 10.1208/s12249-015-0393-y. Epub 2015 Aug 26. AAPS PharmSciTech. 2016. PMID: 26307759 Free PMC article. Review.
-
Recent advances in improving oral drug bioavailability by cocrystals.Bioimpacts. 2018;8(4):305-320. doi: 10.15171/bi.2018.33. Epub 2018 May 31. Bioimpacts. 2018. PMID: 30397585 Free PMC article. Review.
-
Provisional in-silico biopharmaceutics classification (BCS) to guide oral drug product development.Drug Des Devel Ther. 2014 Sep 24;8:1563-75. doi: 10.2147/DDDT.S68909. eCollection 2014. Drug Des Devel Ther. 2014. PMID: 25284986 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources